Department of Molecular & Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, USA.
Nat Commun. 2023 Jul 24;14(1):4445. doi: 10.1038/s41467-023-40096-1.
RAD51C is an enigmatic predisposition gene for breast, ovarian, and prostate cancer. Currently, missing structural and related functional understanding limits patient mutation interpretation to homology-directed repair (HDR) function analysis. Here we report the RAD51C-XRCC3 (CX3) X-ray co-crystal structure with bound ATP analog and define separable RAD51C replication stability roles informed by its three-dimensional structure, assembly, and unappreciated polymerization motif. Mapping of cancer patient mutations as a functional guide confirms ATP-binding matching RAD51 recombinase, yet highlights distinct CX3 interfaces. Analyses of CRISPR/Cas9-edited human cells with RAD51C mutations combined with single-molecule, single-cell and biophysics measurements uncover discrete CX3 regions for DNA replication fork protection, restart and reversal, accomplished by separable functions in DNA binding and implied 5' RAD51 filament capping. Collective findings establish CX3 as a cancer-relevant replication stress response complex, show how HDR-proficient variants could contribute to tumor development, and identify regions to aid functional testing and classification of cancer mutations.
RAD51C 是一种神秘的乳腺癌、卵巢癌和前列腺癌易感性基因。目前,结构缺失和相关功能理解的不足限制了对患者突变的解释仅限于同源定向修复 (HDR) 功能分析。在这里,我们报告了 RAD51C-XRCC3(CX3)与结合的 ATP 类似物的 X 射线共晶结构,并通过其三维结构、组装和未被认识的聚合基序,定义了可分离的 RAD51C 复制稳定性作用。将癌症患者突变映射为功能指南,证实了与 ATP 结合的 RAD51 重组酶匹配,但突出了不同的 CX3 界面。使用 CRISPR/Cas9 编辑的携带有 RAD51C 突变的人类细胞进行分析,结合单分子、单细胞和生物物理测量,揭示了用于 DNA 复制叉保护、重新启动和反转的离散 CX3 区域,这些区域通过 DNA 结合的可分离功能和隐含的 5'RAD51 丝封端来实现。这些发现确立了 CX3 作为与癌症相关的复制应激反应复合物,表明 HDR 功能齐全的变体如何有助于肿瘤的发展,并确定了有助于功能测试和癌症突变分类的区域。